Edgar Correa, DPM
Podiatrist · Raleigh, NCNPI 1194708263
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,101 of the $6,050 with a category attached, or 67.8%. 13 manufacturers reported payments, led by Arthrex at 57.6% of the total. Reporting peaked in 2021 at $3,360 and has fallen 86.0% since, to $470 in 2025.
Across 52 payments — averaging $116.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Southtech Orthopedics$2K
- Tricoast Surgical Solutions LLC$496
- Stryker$134
- Smith+Nephew$73
- Ferring Pharmaceuticals Inc.$53
- plus $193 from 7 others
What the payments were for
- Travel & lodging$1,27221%
- Food & beverage$67711%
- Education$4,10168%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 26 | $3,485 |
| Southtech Orthopedics | 2 | $1,616 |
| Tricoast Surgical Solutions LLC | 3 | $496 |
| Stryker | 4 | $134 |
| Smith+Nephew | 4 | $73 |
| Ferring Pharmaceuticals Inc. | 3 | $53 |
| Johnson & Johnson(2 entities) | 2 | $42 |
| Nevro Corp. | 2 | $38 |
| Pacira Therapeutics, Inc. | 2 | $35 |
| Fidia Pharma USA Inc. | 1 | $26 |
| Paragon 28, Inc. | 1 | $23 |
| Bioventus LLC | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
How this compares
$6,050 in reported general payments places this provider in the 80th percentile of 109 podiatrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 15 | $760 |
| Diclofenac Sodium | 55 | $571 |
| Ciclopirox | 24 | $562 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $436 |
| Gabapentin | 25 | $253 |
| Ketoconazole | 13 | $183 |
| Meloxicam | 14 | $19 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Raleigh
- Jordan MeyersRaleigh$343K
- Alan BoehmRaleigh$8K
- Charles KorbaRaleigh$7K
- Devin GrantRaleigh$7K
- Alyssa CarrollRaleigh$3K
- Christopher GaulandGreenville$56K
- Scott MartinRocky Mount$14K
- Gretchen LawrenceForest City$12K
- William WeilyCharlotte$11K
- Kristin KirbyHuntersville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.